Group 1 - Huayang Intelligent's shareholder, Fosun Weiying, plans to reduce its stake by up to 285.42 million shares, representing no more than 5% of the company [1] - Kangtai Biological's controlling shareholder's concerted actor, Du Xinglian, intends to reduce its stake by up to 272.4 million shares, which is no more than 0.24% of the total share capital [2] - Mindray Medical has submitted an application for H-share issuance and listing on the Hong Kong Stock Exchange [4] Group 2 - Junpu Intelligent's chairman, Liu Yuan, resigned for personal reasons, and Wang Jianfeng was elected as the new chairman [6] - Mingchen Health's actual controller and executives plan to collectively reduce their stake by up to 8.61 million shares, accounting for 3.27% of the total share capital [7] - Zhongheng Design's directors and executives plan to reduce their stake by up to 151.57 million shares, representing no more than 0.55% of the total share capital [9] Group 3 - ST Erya and its actual controller, Zheng Jiping, are still under investigation by the China Securities Regulatory Commission [10] - Qicai Chemical's shareholder, Beijing Fengyan, plans to reduce its stake by up to 399.12 million shares, accounting for 0.98% of the total share capital [11] - Aier Eye Hospital plans to distribute a cash dividend of 0.8 yuan per 10 shares to all shareholders, totaling approximately 744 million yuan [12] Group 4 - Meiri Interactive's actual controller's concerted actor plans to reduce its stake by up to 394.74 million shares, which is 1% of the total share capital [13] - Maipu Medical's pre-IPO shareholder plans to reduce its stake by up to 67.05 million shares, representing no more than 1% of the total share capital [15] - Qinchuan Machine Tool's subsidiary plans to increase its registered capital from 50 million yuan to 200 million yuan, introducing new investors [17] Group 5 - Guiyang Bank's proposed director, Yu Rui, has resigned due to work reasons [19] - Guiyang Bank plans to acquire Xifeng Development Village Bank and establish a branch [20] - Aojing Medical's directors and executives plan to collectively reduce their stake by up to 25.28 million shares, accounting for no more than 0.19% of the total share capital [21] Group 6 - Zhongji Xuchuang intends to issue H-shares and list on the Hong Kong Stock Exchange [22] - ST Huatuo's stock will have its risk warning lifted, changing its name to Shiji Huatuo [25] - *ST Gaohong's stock has been delisted from the Shenzhen Stock Exchange [27] Group 7 - Tianwo Technology plans to publicly transfer a 7.12% stake in Qinghai Haihe Railway Transportation Co., with an assessed value of approximately 8.54 million yuan [28] - Xingye Technology's major shareholder plans to reduce its stake by up to 886.65 million shares, representing no more than 3% of the total share capital [29] - Jiangnan Chemical has successfully acquired 100% equity of Chongqing Shun'an Explosive Materials Co., with a transfer base price of 1 billion yuan [31]

Group 1 - The major shareholder, Fujian Chunhong Equity Investment Partnership (Limited Partnership), plans to reduce its stake in the company by up to 8.8665 million shares, which represents 3% of the company's total share capital [1]

Core Viewpoint - The major shareholder of Xingye Leather Technology Co., Ltd. plans to reduce its stake by up to 3% of the total share capital within three months, which may exert short-term pressure on the stock price [1][4]. Group 1: Reduction Plan Details - The shareholder, Fujian Chunhong Equity Investment Partnership, currently holds 31,464,000 shares, representing 10.65% of the total share capital [2]. - The reduction will be executed through a combination of centralized bidding and block trading, with a maximum of 8,866,500 shares to be sold, equating to 3% of the total share capital [2]. - The reduction period is set to begin approximately from early December 2025 to the end of February 2026, with the selling price determined by market conditions [2]. Group 2: Shareholder Background - Chunhong Investment is an action-in-concert party with the controlling shareholder and holds shares acquired prior to the company's initial public offering in May 2012 [3]. - The shareholder had previously committed not to transfer these shares for 36 months post-IPO, a commitment that has now been fulfilled [3]. - The reduction will not affect the commitments of the company's directors and supervisors regarding share transfers [3]. Group 3: Market Impact - The primary reason for the reduction is stated as "funding needs," which is considered a normal investment exit behavior [4]. - Despite the reduction not changing control, the market may perceive the sale as a cash-out, potentially leading to short-term stock price pressure [4]. - The timing, quantity, and price of the reduction remain uncertain and will depend on market conditions [4]. Group 4: Compliance and Regulatory Aspects - The reduction plan complies with relevant laws and regulations, and there are no prohibitive circumstances for the shareholder to reduce their stake [5]. - The company's board has verified the accuracy and completeness of the information disclosed [5]. - The company will fulfill its disclosure obligations regarding the implementation of the reduction plan as required by regulators [5].

Core Viewpoint - The major shareholder of Xingye Technology plans to reduce its stake in the company by up to 8.8665 million shares, representing 3% of the total share capital, within three months after the announcement date [1] Summary by Category - **Shareholder Actions** - The major shareholder, Chunhong Investment, intends to reduce its holdings through centralized bidding and block trading methods [1] - The reduction will occur within three months following the announcement, starting fifteen trading days after the disclosure [1]

Group 1 - The major shareholder of Xingye Technology, Fujian Chunhong Equity Investment Partnership, plans to reduce its stake by up to 8.8665 million shares, representing 3% of the company's total share capital [1]

证券代码：002674 证券简称：兴业科技 公告编号：2025-067 兴业皮革科技股份有限公司 关于大股东减持股份的预披露公告 信息披露义务人福建省春宏股权投资合伙企业（有限合伙）保证向公司提供 的信息内容真实、准确、完整，不存在虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证信息披露内容与信息披露义务人提供的信息 一致。 特别提示：兴业皮革科技股份有限公司（以下简称"公司"或"本公司"）于近 日接到大股东福建省春宏股权投资合伙企业（有限合伙）（以下简称"春宏投资"） 提交的《股份减持计划告知函》，春宏投资持有本公司 31,464,000 股（占公司总 股本 10.65%），春宏投资计划在本公告披露之日起十五个交易日后的三个月内以 集中竞价和大宗交易方式减持本公司股份累计不超过 8,866,500 股（占本公司总 股本的 3%），其中以集中竞价方式减持股份总数不超过本公司总股本的 1%，以 大宗交易方式减持股份总数不超过本公司总股本的 2%。 一、春宏投资的基本情况 1、股东名称：福建省春宏股权投资合伙企业（有限合伙） 3、减持数量、方式：通过集中竞价及大宗交易的方式累计减持不超过 8,866, ...

Core Viewpoint - The stock of Xingye Technology has experienced fluctuations, with a year-to-date increase of 48.72% but a recent decline in the last five and twenty trading days [1][2]. Group 1: Stock Performance - As of November 3, Xingye Technology's stock price was 13.89 CNY per share, with a market capitalization of 4.105 billion CNY [1]. - The stock has seen a net outflow of 291.17 thousand CNY in principal funds, with large orders accounting for 2.40% of total buying and 12.00% of total selling [1]. - The stock has appeared on the "Dragon and Tiger List" four times this year, with the most recent appearance on September 23, where it recorded a net purchase of 91.1784 million CNY [1]. Group 2: Financial Performance - For the period from January to September 2025, Xingye Technology reported a revenue of 2.014 billion CNY, reflecting a year-on-year growth of 0.01%, while the net profit attributable to shareholders decreased by 63.86% to 39.6558 million CNY [2]. - The company has distributed a total of 1.153 billion CNY in dividends since its A-share listing, with 365 million CNY distributed over the past three years [3]. Group 3: Business Overview - Xingye Technology, established on December 14, 1992, specializes in the development, production, and sales of mid-to-high-end cowhide leather for shoes [1]. - The revenue composition includes leather for bags and belts (63.62%), automotive interior leather (28.47%), and other leather products [1]. - As of September 30, 2025, the number of shareholders increased by 28.28% to 16,600, while the average circulating shares per person decreased by 22.04% to 17,629 shares [2].

Group 1 - The core point of the article is that Xinyi Technology (002674.SZ) reported an increase in institutional ownership, with a total of 1.56 billion shares held by 8 institutional investors, representing 52.86% of the total share capital, which is an increase of 3.11 percentage points compared to the previous quarter [1] Group 2 - Among the institutional investors, notable names include Fujian Wanxing Equity Investment Partnership, China Construction Bank's fund, and J.P. Morgan Securities PLC [1] - In terms of public funds, 2 new public funds were disclosed this quarter, while 20 public funds were not disclosed compared to the previous quarter [1] - The newly disclosed public funds include Yongying Advanced Manufacturing Mixed Fund and Minsheng Jia Yin National Index Enhanced A [1]

Core Viewpoint - Xingye Technology is a leading domestic manufacturer of mid-to-high-end cowhide leather for shoes, with a full industry chain advantage and a focus on supplying various overseas brands [1] Group 1: Business Performance - In Q3 2025, Xingye Technology reported revenue of 2.014 billion yuan, ranking third in the industry, with the top competitor, Weixing Co., achieving 3.633 billion yuan [2] - The company's net profit for the same period was 826.674 million yuan, also ranking third, while Weixing Co. led with a net profit of 587 million yuan [2] - The main business segments include leather for bags and belts (855.2 million yuan, 63.62%), automotive interior leather (381 million yuan, 28.47%), and other leather products [2] Group 2: Financial Ratios - As of Q3 2025, Xingye Technology's debt-to-asset ratio was 42.96%, up from 39.92% year-on-year, exceeding the industry average of 35.48% [3] - The gross profit margin for Q3 2025 was 18.72%, down from 21.27% year-on-year, and below the industry average of 28.37% [3] Group 3: Executive Compensation - The chairman, Wu Huachun, received a salary of 1.4 million yuan in 2024, a decrease of 40,000 yuan from the previous year [4] - The president, Sun Huiyong, earned 1.4132 million yuan in 2024, down from 1.4505 million yuan in 2023 [4] Group 4: Shareholder Information - As of September 30, 2025, the number of A-share shareholders increased by 28.28% to 16,600, while the average number of shares held per shareholder decreased by 22.04% [5] - The company reported a revenue of 700 million yuan in Q2 2025, a year-on-year increase of 7%, but a net profit decrease of 45% [5] Group 5: Strategic Developments - Xingye Technology signed a strategic cooperation agreement with Suzhou Nengsida to jointly develop flexible electronic skin based on natural leather and bio-based materials [6] - The company is expanding its overseas presence with factories in Indonesia and Vietnam, which will aid in market expansion [5][6] - Forecasted EPS for 2025-2027 is 0.41 yuan, 0.56 yuan, and 0.73 yuan respectively, maintaining a "buy" investment rating [6]

1、全体监事以 3 票赞成、0 票反对、0 票弃权，通过了《关于公司 2025 年 第三季度报告的议案》。 监事会认为：董事会编制和审议公司 2025 年第三季度报告的程序符合法律、 行政法规和中国证监会的规定，公司 2025 年第三季度报告的内容能够真实、准 确、完整地反映公司的实际情况。 《兴业皮革科技股份有限公司 2025 年第三季度报告全文》具体内容详见巨 潮资讯网（www.cninfo.com.cn）。 证券代码：002674 证券简称： 兴业科技 公告编号：2025-066 兴业皮革科技股份有限公司 第六届监事会第十二次会议决议公告 本公司及监事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 兴业皮革科技股份有限公司（以下简称"公司"）第六届监事会第十二次会议 的通知于 2025 年 10 月 17 日以直接送达、传真、电子邮件并电话确认等方式送 达公司全体监事。会议于 2025 年 10 月 27 日下午 2:00 在公司办公楼二楼会议室 以现场的方式召开。本次会议应出席监事 3 名，实际出席监事 3 名，由监事会主 席苏建忠先生主持 ...